Cover Image

Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals

BackgroundPatients with type 2 diabetes mellitus (T2DM) are at increased risk for COVID-19 related morbidity and mortality. Antibody response to COVID-19 vaccine in T2DM patients is not very clear. The present work aims to evaluate the antibody response to the inactivated SARS-CoV-2 vaccine in this...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yandong Cheng (Author), Ping Shen (Author), Yue Tao (Author), Wenjun Zhang (Author), Biyun Xu (Author), Yan Bi (Author), Zhen Han (Author), Yi-Hua Zhou (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Self-Reported adverse events among Chinese healthcare workers immunized with COVID-19 vaccines composed of inactivated SARS-CoV-2
by: Yandong Cheng, et al.
Published: (2022)

Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines
by: Ziyu Liu, et al.
Published: (2024)

Neutralizing Antibody Response by Inactivated SARS-CoV-2 Vaccine on Healthcare Workers
by: Nataniel Tandirogang, et al.
Published: (2023)

Incidence of SARS-CoV-2 infection in children shortly after ending zero-COVID-19 policy in China on December 7, 2022: a cross-sectional, multicenter, seroepidemiological study
by: Yi-Hua Zhou, et al.
Published: (2023)

Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain
by: Ping-Han Huang, et al.
Published: (2021)

How to Increase the Immunogenicity of SARS-COV-2 Inactivated Vaccines?
by: Yousef Khadivi
Published: (2021)

Importance of timely management of patients in reducing fatality rate of coronavirus disease 2019
by: Yuzhu Peng, et al.
Published: (2020)

VITT with inactivated SARS-CoV-2 vaccine - index case
by: Kanta Devi, et al.
Published: (2022)

Prevalence of antibody to hepatitis B surface antigen among qualified blood donors in Nanjing, China
by: Yi-Hua Zhou, et al.
Published: (2023)

Increased body mass index linked to decreased neutralizing antibody titers of inactivated SARS‐CoV‐2 vaccine in healthcare workers
by: Juan Hu, et al.
Published: (2023)

Nanoformulation Composed of Ellagic Acid and Functionalized Zinc Oxide Nanoparticles Inactivates DNA and RNA Viruses
by: Khaled AbouAitah, et al.
Published: (2021)

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
by: Tao-Hsin Tung, et al.
Published: (2022)

Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series
by: Ting Zhao, et al.
Published: (2022)

Antibody response to SARS-CoV-2 vaccines among hospitalized patients in China: a case-control study
by: Fei-Ping Li, et al.
Published: (2022)

Adverse events after COVID-19 vaccination self-reported by healthcare workers are reliable
by: Yandong Cheng, et al.
Published: (2022)

Neutralization antibody titers against SARS-CoV-2 in an infant born to a mother with COVID-19
by: Yi-Ching Chen, et al.
Published: (2021)

Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate
by: Kento Tazawa, et al.
Published: (2023)

In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse
by: Manjunath Shet, et al.
Published: (2022)

Ozone Treatment Is Insufficient to Inactivate SARS-CoV-2 Surrogate under Field Conditions
by: Natalia Mazur-Panasiuk, et al.
Published: (2021)

Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination
by: Zhao WM, et al.
Published: (2022)

Characteristics of local COVID-19 cases aged ≥ 60 years in Zhejiang province during epidemic period dominantly due to SARS-CoV-2 Omicron variant infection
by: Bi-yao LIU, et al.
Published: (2022)

The impact of sample processing on the rapid antigen detection test for SARS-CoV-2: Virus inactivation, VTM selection, and sample preservation
by: Haiwei Zhou, et al.
Published: (2021)

Perniosis-like erythema after SARS-CoV2 infection reactivated by vaccination with inactivated virus
by: Lucas Campos Garcia, et al.
Published: (2023)

Evaluation and Clinical Validation of Guanidine-Based Inactivation Transport Medium for Preservation of SARS-CoV-2
by: Hesti L. Wiraswati, et al.
Published: (2022)

Inactivation of SARS-CoV-2 by 2 commercially available Benzalkonium chloride-based hand sanitizers in comparison with an 80% ethanol-based hand sanitizer
by: Brandon L. Herdt, et al.
Published: (2021)

Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers
by: Ahmet Soysal, et al.
Published: (2021)

COVID-19 vaccination coverage among adolescents aged 12-17 years in three provinces of eastern China: A cross-sectional survey, 2021
by: Taishun Li, et al.
Published: (2022)

Contemporary Composers
by: Mason, Daniel Gregory, 1873-1953

The Romantic Composers
by: Mason, Daniel Gregory, 1873-1953

Waning antibodies to SARS-CoV-2 - Don't panic
by: Benjamin Meyer
Published: (2021)

Neutralizing and enhancing antibodies against SARS-CoV-2
by: Yafei Liu, et al.
Published: (2022)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
by: Romain Rouet, et al.
Published: (2021)

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
by: Lairun Jin, et al.
Published: (2022)

Immune response and safety of inactivated SARS-CoV-2 vaccines during pregnancy: a real-world observational study
by: Yajie Gong, et al.
Published: (2023)

Temporal profile of specific antibody against SARS-CoV-2 among infected people: a literature study
by: Wen WU, et al.
Published: (2022)

Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers
by: Amit Bansal, et al.
Published: (2023)

Antibody responses induced by Sputnik V vaccine in individuals previously infected with SARS-CoV-2
by: Silvina Raiden, et al.
Published: (2022)

Protective effectiveness of previous infection against subsequent SARS-Cov-2 infection: systematic review and meta-analysis
by: Wei-Hua Hu, et al.
Published: (2024)

Dynamic Changes of Antibodies to SARS-CoV-2 in Close Contacts
by: Yao J, et al.
Published: (2021)

Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months
by: Rima R. Sahay, et al.
Published: (2022)